This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Charles B. Carpenter, MD; John P. Merrill, MD

Arch Intern Med. 1969;123(5):501-513.

Abstract
Improved success in clinical renal transplantation is dependent upon optimal matching of donor and recipient tissue antigens, and upon more effective and less toxic means of immunosuppression. Variations in the clinical and pathological manifestations of rejection are a result of the individual's response to foreigntissue antigens which are as yet incompletely defined, and perhaps also to individual differences with regard to the effects of immunosuppressive therapy. In addition to leukocyte typing for HL-A antigens, avoidance of presensitization is a crucial problem for a transplant program. Currently employed therapy, including cytotoxic agents and antilymphocyte globulin (ALG), is not always effective and frequently produces serious infectious complications. Improved methods for production and testing of ALG are needed, as well as investigation of other means of tolerance induction.

Author Affiliations
Boston

Footnotes
Received for publication Nov 5, 1968; accepted Jan 17, 1969.

From the Department of Medicine, Peter Bent Brigham Hospital, and Harvard Medical School, Boston. Dr. Carpenter is a recipient of a National Institutes of Health career development award; Dr. Merrill is an investigator of the Howard Hughes Medical Institute, Miami, Fla.

Reprint requests to 721 Huntington Ave, Boston 02115 (Dr. Carpenter).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ultrasonic Testing in Human Renal Allografts
Winterberger et al.
JAMA 1972;219:475-479.
ABSTRACT